Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child-Pugh B cirrhosis.

Chapin, William J; Hwang, Wei-Ting; Karasic, Thomas B; McCarthy, Anne Marie; Kaplan, David E

Chapin, William J; Hwang, Wei-Ting; Karasic, Thomas B; McCarthy, Anne Marie; Kaplan, David E.

Afiliación

Chapin WJ; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Hwang WT; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Karasic TB; Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
McCarthy AM; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Kaplan DE; Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Cancer Med ; 12(1): 189-199, 2023 01.

Article en En | MEDLINE | ID: mdl-35652419

Asunto(s)

Antineoplásicos; Carcinoma Hepatocelular; Neoplasias Hepáticas; Humanos; Sorafenib/uso terapéutico; Carcinoma Hepatocelular/patología; Nivolumab/efectos adversos; Antineoplásicos/efectos adversos; Estudios Retrospectivos; Neoplasias Hepáticas/patología; Niacinamida/uso terapéutico; Compuestos de Fenilurea/uso terapéutico; Cirrosis Hepática/complicaciones; Cirrosis Hepática/tratamiento farmacológico; Resultado del Tratamiento

Palabras clave

comparative effectiveness research; hepatocellular carcinoma; liver cirrhosis; nivolumab; propensity score; proportional hazards models; sorafenib

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Métodos Terapéuticos y Terapias MTCI: Terapias_biologicas / Aromoterapia Asunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Med Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google